Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Inflammatory Bowel Diseases

Free Subscription 15.07.2024 3 Aliment Pharmacol Ther 3 Am J Gastroenterol 1 BMC Gastroenterol 4 Clin Gastroenterol Hepatol 6 Eur J Gastroenterol Hepatol 1 Gastroenterol Hepatol 2 Gut 9 Inflamm Bowel Dis 3 J Crohns Colitis 1 J Gastroenterol 1 J Pediatr 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Aliment Pharmacol Ther

1. WEWER MD, Nordestgaard RLM, Malham M, Wewer V, et al
   Editorial: Treatments of inflammatory bowel disease across age-spectrum-Are they the same? Authors' reply.
   Aliment Pharmacol Ther. 2024 Jul 8. doi: 10.1111/apt.18163.
   PubMed        
   
   
2. HO AHY, Mak JWY
   Editorial: Treatments for inflammatory bowel disease across the age spectrum-Are they the same?
   Aliment Pharmacol Ther. 2024 Jul 8. doi: 10.1111/apt.18143.
   PubMed        
   
   
3. SELINGER CP, Baillie S, Pollok R
   Letter: Addressing opioid exposure and associated harms in patients with IBD.
   Aliment Pharmacol Ther. 2024;60:423-424.
   PubMed        
   
   

   
   Am J Gastroenterol

4. KARLQVIST S, Sachs MC, Eriksson C, Cao Y, et al
   Comparative risk of serious infection with vedolizumab vs anti-TNF in inflammatory bowel disease: results from nationwide Swedish registers.
   Am J Gastroenterol. 2024 Jul 12. doi: 10.14309/ajg.0000000000002961.
   PubMed         Abstract available
   
   
5. TANDON P, Huang V, Feig DS, Saskin R, et al
   Recent Immigrants With Inflammatory Bowel Disease Have Significant Healthcare Utilization From Preconception to Postpartum: A Population Cohort Study.
   Am J Gastroenterol. 2024;119:1346-1354.
   PubMed         Abstract available
   
   
6. KOCHHAR GS, Khataniar H, Jairath V, Farraye FA, et al
   Comparative Effectiveness of Upadacitinib and Tofacitinib in Ulcerative Colitis: A U.S. Propensity-Matched Cohort Study.
   Am J Gastroenterol. 2024 Jul 5. doi: 10.14309/ajg.0000000000002947.
   PubMed         Abstract available
   
   

   
   BMC Gastroenterol

7. FU H, Zheng X, Xu K, Zhang Y, et al
   Self-assembled nanoparticles of costunolide and glycyrrhizic acid for enhanced ulcerative colitis treatment.
   BMC Gastroenterol. 2024;24:223.
   PubMed         Abstract available
   
   

   
   Clin Gastroenterol Hepatol

8. ROCHA CH, Turpin W, Borowski K, Stempak JM, et al
   After surgically induced remission, ileal and colonic mucosa-associated microbiota predicts Crohn's disease recurrence.
   Clin Gastroenterol Hepatol. 2024 Jul 3:S1542-3565(24)00592.
   PubMed         Abstract available
   
   
9. INNOCENTI T, Rocco C, Lynch EN, Milla M, et al
   Applicability of the International Bowel Ultrasound Segmental Activity Score (IBUS-SAS) to ulcerative colitis: a preliminary study.
   Clin Gastroenterol Hepatol. 2024 Jul 4:S1542-3565(24)00607.
   PubMed        
   
   
10. GAO L, Fang K, Dong X, Bai J, et al
    Additional yield of random biopsy in patients with inflammatory bowel disease: A systematic review and meta-analysis.
    Clin Gastroenterol Hepatol. 2024 Jul 5:S1542-3565(24)00556.
    PubMed         Abstract available
    
    
11. SILVERMAN AL, Shung D, Stidham RW, Kochhar GS, et al
    How Artificial Intelligence Will Transform Clinical Care, Research, and Trials for Inflammatory Bowel Disease.
    Clin Gastroenterol Hepatol. 2024 Jul 9:S1542-3565(24)00598.
    PubMed         Abstract available
    
    

    
    Eur J Gastroenterol Hepatol

12. TORIS LD, Minsart CF, Husson CP, Franchimont DP, et al
    Lipopolysaccharide-binding protein in Crohn's disease patients: a promising noninvasive biomarker monitoring disease activity.
    Eur J Gastroenterol Hepatol. 2024 Jun 26. doi: 10.1097/MEG.0000000000002811.
    PubMed         Abstract available
    
    
13. NEAMTI L, Drugan TC, Drugan C, Silaghi C, et al
    Assessing seasonal variations of biomarkers in inflammatory bowel disease.
    Eur J Gastroenterol Hepatol. 2024;36:993-999.
    PubMed         Abstract available
    
    
14. KHALAF R, Sciberras M, Ellul P
    The role of the fecal microbiota in inflammatory bowel disease.
    Eur J Gastroenterol Hepatol. 2024 Jul 8. doi: 10.1097/MEG.0000000000002818.
    PubMed         Abstract available
    
    
15. NAQVI HA, Delungahawatta T, Atarere JO, Bandaru SK, et al
    Evaluation of online chat-based artificial intelligence responses about inflammatory bowel disease and diet.
    Eur J Gastroenterol Hepatol. 2024 Jul 8. doi: 10.1097/MEG.0000000000002815.
    PubMed         Abstract available
    
    
16. MILIOLI NJ, Fernandes MV, Correa TL, Antunes V, et al
    Vedolizumab versus ustekinumab in Crohn's disease with prior anti-tumor necrosis factor failure: an updated meta-analysis.
    Eur J Gastroenterol Hepatol. 2024 Jul 2. doi: 10.1097/MEG.0000000000002817.
    PubMed         Abstract available
    
    
17. KOLEHMAINEN S, Rautakorpi J, Loyttyniemi E, Af Bjorkesten CG, et al
    Real-life experiences of switching from intravenous to subcutaneous vedolizumab maintenance therapy in patients with inflammatory bowel disease.
    Eur J Gastroenterol Hepatol. 2024 Jul 8. doi: 10.1097/MEG.0000000000002816.
    PubMed         Abstract available
    
    

    
    Gastroenterol Hepatol

18. VIDAL-DELSO M, Fortuny M, Gonzalez-Gonzalez L, Pelach A, et al
    Strongyloides stercolaris hiperinfection syndrome in ulcerative colitis treated with corticotherapy. The importance of strongyloides screening.
    Gastroenterol Hepatol. 2024 Jul 9:502230. doi: 10.1016/j.gastrohep.2024.502230.
    PubMed        
    
    

    
    Gut

19. BEDKE T, Stumme F, Tomczak M, Steglich B, et al
    Protective function of sclerosing cholangitis on IBD.
    Gut. 2024 Jun 5:gutjnl-2023-330856. doi: 10.1136/gutjnl-2023-330856.
    PubMed         Abstract available
    
    
20. ADOLPH TE, Meyer M, Jukic A, Tilg H, et al
    Heavy arch: from inflammatory bowel diseases to metabolic disorders.
    Gut. 2024;73:1376-1387.
    PubMed         Abstract available
    
    

    
    Inflamm Bowel Dis

21. QIN X
    Antibacterial Agents May Have Shifted Impacts on Inflammatory Bowel Diseases Along with Decrease in Gut Bacteria.
    Inflamm Bowel Dis. 2024;30:1228-1231.
    PubMed        
    
    
22. OUAHED JD, Griffith A, Collen LV, Snapper SB, et al
    Breaking Down Barriers: Epithelial Contributors to Monogenic IBD Pathogenesis.
    Inflamm Bowel Dis. 2024;30:1189-1206.
    PubMed         Abstract available
    
    
23. LETHEN I, Lechner-Grimm K, Gabel M, Knauss A, et al
    Tofacitinib Affects M1-like and M2-like Polarization and Tissue Factor Expression in Macrophages of Healthy Donors and IBD Patients.
    Inflamm Bowel Dis. 2024;30:1151-1163.
    PubMed         Abstract available
    
    
24. SANTIAGO P, Quinn KP, Chen J, Friton JJ, et al
    Altered Bile Acid and Pouch Microbiota Composition in Patients With Chronic Pouchitis.
    Inflamm Bowel Dis. 2024;30:1062-1070.
    PubMed         Abstract available
    
    
25. VESTERGAARD T, Kelsen J, Julsgaard M
    Specialized Prenatal Care for Women With IBD Makes a Difference.
    Inflamm Bowel Dis. 2024;30:1218-1219.
    PubMed        
    
    
26. LOEB L, Kinnucan J
    Cannabis Use in IBD Is Associated With Increased Healthcare Utilization but not With Surgery or Death.
    Inflamm Bowel Dis. 2024;30:1215-1217.
    PubMed        
    
    
27. RYAN K, Salozzo C, Schwartz S, Hart M, et al
    Following Through: The Impact of Culinary Medicine on Mediterranean Diet Uptake in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2024 Jul 5:izae141. doi: 10.1093.
    PubMed         Abstract available
    
    
28. URQUHART SA, Chedid VG, Kane SV
    Use of Upadacitinib as Salvage Therapy for Ulcerative Colitis in Pregnancy: A Case Report.
    Inflamm Bowel Dis. 2024 Jul 5:izae146. doi: 10.1093.
    PubMed        
    
    
29. KERBIRIOU C, Dickson C, Nichols B, Logan M, et al
    Treatment of Active Crohn's Disease With Exclusive Enteral Nutrition Diminishes the Immunostimulatory Potential of Fecal Microbial Products.
    Inflamm Bowel Dis. 2024 Jul 9:izae124. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Crohns Colitis

30. LEIBOVITZH H, Nayeri S, Borowski K, Hernandez-Rocha C, et al
    Inflammatory bowel disease associated with primary sclerosing cholangitis is associated with an altered gut microbiome and bile acid profile.
    J Crohns Colitis. 2024 Jul 9:jjae096. doi: 10.1093.
    PubMed         Abstract available
    
    
31. DE FRANCISCO R, Perez-Martinez I, Castano-Garcia A, Carballo-Folgoso L, et al
    Do patients with inflammatory bowel disease really know what other immune-mediated inflammatory diseases they are diagnosed with?
    J Crohns Colitis. 2024 Jul 9:jjae109. doi: 10.1093.
    PubMed         Abstract available
    
    
32. HUANG CW, Yen HH, Chen YY
    Rescue Therapies for Steroid-Refractory Acute Severe Ulcerative Colitis: A Systemic Review and Network Meta-analysis.
    J Crohns Colitis. 2024 Jul 9:jjae111. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Gastroenterol

33. MASSIRONI S, Furfaro F, Bencardino S, Allocca M, et al
    Immunity in digestive diseases: new drugs for inflammatory bowel disease treatment-insights from Phase II and III trials.
    J Gastroenterol. 2024 Jul 9. doi: 10.1007/s00535-024-02130.
    PubMed         Abstract available
    
    

    
    J Pediatr

34. GERHOLD K, Al-Azazi S, El-Matary W, Katz LY, et al
    Healthcare Utilization and Direct Costs Prior to Subspecialty Care in Children with Chronic Pain Compared with Other Chronic Childhood Diseases: A Cohort Study.
    J Pediatr. 2024 Apr 4:114046. doi: 10.1016/j.jpeds.2024.114046.
    PubMed         Abstract available
    
    

    
    PLoS One

35. KHANMOHAMMADI S, Sheidaei A, Alatab S, Tabatabaei-Malazy O, et al
    Sex and age differences in inflammatory bowel disease patients; a nationwide study based on Iranian Registry of Crohn's and Colitis (IRCC).
    PLoS One. 2024;19:e0304792.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Inflammatory Bowel Diseases is free of charge.